The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Cellular and Molecular Mechanisms of Action of Linuron: An Antiandrogenic Herbicide that Produces Reproductive Malformations in Male Rats
Abstract
Antiandrogenic chemicals alter sex differentiation by several different mechanisms. Some, like flutamide, procymidone, or vinclozolin compete with androgens for the androgen receptor (AR), inhibit AR-DNA binding, and alter androgen-dependent gene expression in vivo and in vitro. Finasteride and some phthalate esters demasculinize male rats by inhibiting fetal androgen synthesis. Linuron, which is a weak competitive inhibitor of AR binding (reported Ki of 100 microM), alters sexual differentiation in an antiandrogenic manner. However, the pattern of malformations more closely resembles that produced by the phthalate esters than by vinclozolin treatment. The present study was designed to determine if linuron acted as an AR antagonist in vitro and in vivo. In vitro, we (1) confirmed the affinity of linuron for the rat AR, and found (2) that linuron binds human AR (hAR), and (3) acts as an hAR antagonist. Linuron competed with an androgen for rat prostatic AR (EC(50) = 100-300 microM) and human AR (hAR) in a COS cell-binding assay (EC(50) = 20 microM). Linuron inhibited dihydrotestosterone (DHT)-hAR induced gene expression in CV-1 and MDA-MB-453-KB2 cells (EC(50) = 10 microM) at concentrations that were not cytotoxic. In short-term in vivo studies, linuron treatment reduced testosterone- and DHT-dependent tissue weights in the Hershberger assay (oral 100 mg/kg/d for 7 days, using castrate-immature-testosterone propionate-treated male rats; an assay used for decades to screen for AR agonists and antagonists) and altered the expression of androgen-regulated ventral prostate genes (oral 100 mg/kg/d for 4 days). Histological effects of in utero exposure to linuron (100 mg/kg/d, day 14-18) or DBP (500 mg/kg/d, day 14 to postnatal day 3) on the testes and epididymides also are shown here. Taken together, these results support the hypothesis that linuron is an AR antagonist both in vivo and in vitro, but it remains to be determined if linuron alters sexual differentiation by additional mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kelce, W. R., Monosson, E., Gamcsik, M. P., Laws, S. C., & Gray, L. E. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1117 · Cited by 542
Gray, L. E., Ostby, J. S., & Kelce, W. R. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1227 · Cited by 491
Self-citationMylchreest, E., Sar, M., Cattley, R. C., & Foster, P. M. D. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8643 · Cited by 440
Kelce, W. R., Lambright, C. R., Gray, L. E., & Roberts, K. P. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.7966 · Cited by 353
Self-citation
Cited by
Environmental Signaling: What Embryos and Evolution Teach Us About Endocrine Disrupting Chemicals
McLachlan, J. A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.3.0432 · Cited by 608
Raun Andersen, H., Vinggaard, A. M., Høj Rasmussen, T., Gjermandsen, I. M., & Cecilie Bonefeld-Jørgensen, E. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9347 · Cited by 603
Kojima, H., Katsura, E., Takeuchi, S., Niiyama, K., & Kobayashi, K. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6649 · Cited by 510
Effects of environmental antiandrogens on reproductive development in experimental animals
Gray, L. E. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.3.248 · Cited by 473
Hotchkiss, A. K., Rider, C. V., Blystone, C. R., Wilson, V. S., Hartig, P. C., Ankley, G. T., Foster, P. M., Gray, C. L., & Gray, L. E. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn030 · Cited by 460
Metadata
- Authors
- Lambright, C.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-08-01
- Volume
- 56
- Issue
- 2
- Pages
- 389-399
- ISSN
- 1096-0929 (ISSN-L)
- OpenAlex
- W2158537274
- Cited by
- 214
- References
- 4
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.